WTLEB continues emergency medical coverage concerning the unidentified prescription medication known in some systems as Velari. No manufacturer, approval record, research sponsor, patent holder, production site, or distribution mechanism has been verified. Despite an international recall, sealed bottles continue appearing in pharmacies, hospitals, warehouses, controlled facilities, and private homes.
Authorities confirm that disposal and destruction do not prevent replacement inventory from appearing. Listeners are advised not to ingest the medication, not to rely on changing instructions printed on containers, and not to repeatedly attempt disposal if a bottle returns. Possession alone has not been shown to cause physiological changes.
Patients previously exposed require medical evaluation even when they report improved health. Continued weight loss, reduced sleep requirements, altered temperature regulation, changes in blood chemistry, metabolic efficiency, and bone density are being documented after treatment ends. Researchers state that these changes appear statistically complementary across affected populations, though no purpose has been established.
No responsible party has communicated with regulators. No explanation accounts for the medication’s entry into medical systems, its continued circulation, or the coordinated changes now observed in millions of patients. Routine programming continues between advisories.
Podden och tillhörande omslagsbild på den här sidan tillhör
WTLEB 1720 AM. Innehållet i podden är skapat av WTLEB 1720 AM och inte av,
eller tillsammans med, Poddtoppen.
